| 0 (0%) | 10-06 18:35 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 28.66 | 1-year : | 30.71 |
| Resists | First : | 24.54 | Second : | 26.29 |
| Pivot price | 22.95  |
|||
| Supports | First : | 21.7 | Second : | 18.05 |
| MAs | MA(5) : | 22.18 |
MA(20) : | 23.35 |
| MA(100) : | 24.96 |
MA(250) : | 25.09 |
|
| MACD | MACD : | -0.8 |
Signal : | -0.7 |
| %K %D | K(14,3) : | 17.7 |
D(3) : | 13.9 |
| RSI | RSI(14): 40.7 |
|||
| 52-week | High : | 27.25 | Low : | 21.7 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ BMN ] has closed above bottom band by 44.6%. Bollinger Bands are 181.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 27 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 23.09 - 23.18 | 23.18 - 23.26 |
| Low: | 21.56 - 21.66 | 21.66 - 21.76 |
| Close: | 22.58 - 22.76 | 22.76 - 22.92 |
Sun, 04 Oct 2026
Can Chinese Nuclear Funding Fast-Track Bannerman's (ASX:BMN) Etango? - Kalkine Media
Mon, 28 Sep 2026
Total liabilities of BlackRock 2037 Municipal Target Term Trust – NYSE:BMN - TradingView
Fri, 25 Sep 2026
Blackrock 2037 Municipal Target Term Trust (BMN) - Live Price & How to Invest from India - INDmoney
Mon, 10 Aug 2026
BioMarin scraps BMN 401, ending its $270 million Inozyme bet - The Pharma Letter
Fri, 07 Aug 2026
BioMarin drops BMN 401 following unsuccessful pivotal trial - AllSci
Tue, 16 Jun 2026
BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026 - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 6 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 26 (%) |
| Shares Short | 18 (K) |
| Shares Short P.Month | 14 (K) |
| EPS | 2.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 10.3 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0.09 |
| Forward Dividend | 0 |
| Dividend Yield | 0.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|